| INTRODUC TI ON
Orthotopic liver transplantation (OLT) has become the standard care for patients with end-stage liver disease and those with hepatic malignancies. 1 Ischemia-reperfusion injury (IRI), a leading cause of early graft dysfunction, represents a major risk factor in the development of acute/chronic rejection, and contributes to the shortage of donor organs. 2 Thus, novel IR-targeted strategies are needed to improve clinical outcomes and expand donor organ pool. Despite its clinical importance, however, the mechanisms that account for liver IRI are not fully appreciated.
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Liver IR damage, an innate immune-driven inflammation, is followed by the hepatocellular death. The cellular IR stress primes secretion of damage-associated molecular patterns, which trigger inflammatory cytokines to further hepatocyte death. In addition to macrophages, neutrophils also serve as early effectors in hepatic IRI by generating/diffusing reactive oxygen species (ROS) and disturbing homeostasis to trigger mitochondrial dysfunction and cell death. 4, 5 Indeed, systemic neutrophil depletion attenuated liver IRI by suppressing hepatic neutrophil accumulation.
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Heme oxygenase-1 (HO-1; HMOX1; hsp32), the inducible isoform of heme oxygenase catalyzing the degradation of heme into biliverdin, iron, and carbon monoxide, exerts antioxidative and anti-inflammatory functions. 7 We reported on benefits of HO-1 induction in hepatic IRI rodent models, using gene transfer, 8, 9 and macrophage-based therapies. 10, 11 With macrophage recognized as a key mediator of innate inflammation, HO-1 cytoprotection is attributed to its regulation in IR-stressed liver. 12, 13 Others have shown that cobalt protoporphyrin (chemical HO-1 inducer) decreased neutrophil superoxide production and suppressed neutrophil migration, 14, 15 implying neutrophil regulation as an integral part of the HO-1 cytoprotective phenotype. However, by decreasing BACH1
and increasing NRF2 protein levels, cobalt protoporphyrin acts indirectly on HO-1, 16 whereas gene specific HO-1 function in neutrophil regulation remains to be defined.
We have reported that posttransplant HO-1 expression negatively correlated with the severity of IRI in liver transplant patients. model. 17 By contrast, in a mouse cold IRI-OLT model, adjunctive infusion of HO-1-overexpressing bone marrow-derived macrophages (BMDM) increased graft HO-1 levels; whereas HO-1-silenced (siRNA) BMDM decreased graft HO-1 expression, as compared with unmodified BMDM infusion. 10, 18 Although in murine models, liverinfiltrating host BMDM may affect HO-1 expression/function at the graft site, it remains unknown whether recipient-derived HO-1 may influence hepatic HO-1 levels and IRI severity in OLT. In humans, genetic HO-1 induction seems to govern its expression profile, with studies focusing on donor basal HO-1 levels, and no insights into recipients' HO-1 inducibility. 19, 20 In this study, we analyzed whether recipient-derived HO-1 may affect liver graft HO-1 levels and function. with UW solution to its removal from the cold storage for implantation. Recipient venous blood was collected within the hour prior to the transplant and on postoperative day 1 (POD1). The hepatocellular injury was evaluated by serum alanine aminotransferase (sALT).
Protocol Tru-Cut needle biopsies (Bx) from the left hepatic lobe were obtained during back-table preparation (prior to the put-in);
and 2 hours after portal reperfusion (prior to the abdominal closure).
| Animals
Myeloid-specific HO-1 deficient (mHO-1 KO; C57BL/6) mice were generated. 22 In brief, floxed HO-1 KO mice were crossed with lysM (lysozyme M) Cre transgenic mice. 
| Mouse orthotopic liver transplantation
We used a mouse model of ex vivo hepatic cold storage and transplantation. 21, 24 To mimic "marginal" human OLT, donor livers were stored in UW solution at 4°C for 18 hours prior to transplant into syngeneic recipients. Liver graft and serum were collected at 6 hours of reperfusion, the peak of hepatocellular damage in this model. The sham group underwent the same procedures except for OLT.
| Hepatocellular function assay
Mouse serum alanine transaminase (sALT) and aspartate transaminase (sAST), an indicator of hepatocellular injury, were measured by IDEXX Laboratories (Westbrook, ME).
| OLT histology and IRI grading
Formalin-fixed paraffin-embedded liver sections (5 µm) were stained with hematoxylin and eosin (H&E). The severity of IRI was graded using Suzuki's criteria. 
| Immunofluorescence
Mouse livers were stained with rabbit anti-CD11b Ab 
| Bone marrow-derived macrophage culture
Bone marrow-derived macrophages were generated, as described.
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In brief, bone marrow cells were obtained from the femurs and tibias, cultured in 15% L929-conditioned medium for 7 days, and used for in vitro study. 
| Neutrophil isolation and flow cytometry

| Quantitative RT-PCR analysis
RNA extracted with RNAse Mini Kit (Qiagen, Germantown, MD) was reverse-transcribed into cDNA. PCR was performed using QuantStudio 3 (Applied Biosystems, Foster City, CA). The primer sequences are listed (Table S1 ). The target gene expression was normalized to housekeeping HPRT or β-actin.
| ELISA
Serum MCP1/TNFα concentration was measured by ELISA kits (Thermo Scientific), according to the manufacturer's protocol.
| Myeloperoxidase (MPO) activity assay
The presence of MPO was used as an index of neutrophil accumulation in the liver. The change in absorbance was measured spectrophotometrically at 655 nm. One unit of MPO activity was defined as the quantity of enzyme degrading 1 µmol peroxide per minute at 25°C per gram of tissue. 
| Statistical analysis
Group comparisons were performed using a Student t test for mouse experiments, and Mann-Whitney U test was used for human data.
Spearman's correlation coefficient (r) was used to evaluate the strength of linear relationship between variables. The cumulative survival rate was analyzed by Kaplan-Meier method, and differences were compared using a log-rank test. JMP for Windows 8.0 (SAS Institute, Cary, NC) was used for statistical analyses. A P < .05 was considered statistically significant. Figure 1B . There was no significant correlation between basal hepatic HO-1 expression and donor demographics, preprocurement blood tests, duration of brain ischemia, or cold ischemia times (Table S2) . We also found no significant correlation between posttransplant HO-1 levels and donor/recipient demographics, preoperative blood tests, duration of brain or cold ischemia time, race, disease etiology, presence of hepatocellular carcinoma, ABO-compatibility, model for end-stage liver disease (MELD) score, pretransplant dialysis, or intra-operative blood loss (Table S3 ). Unlike basal HO-1 levels, which failed to significantly correlate with sALT at POD1 (r = −0.2138, P = .1320, Figure 1C ), posttransplant HO-1 correlated negatively with sALT at POD1 (r = −0.3306, P = .0178, Figure 1D ). This indicates that posttransplant rather than basal HO-1 levels were essential for improved hepatocellular function in OLT recipients. 
| RE SULTS
| Recipient myeloid HO-1 deficiency accelerates hepatocellular damage in mouse OLT
We next asked whether suppression of HO-1 at the graft site, Figure 4C ); enhanced cleaved caspase-3 (P = .0077, Figure S4A) ; and increased frequency of TUNEL+ cells (P = .0011, Figure S4B ). Thus, suppression of graft HO-1 levels due to recipient myeloid HO-1 deficiency exacerbated IR damage in OLT.
| OLTs in mHO-1 KO recipients exhibit increased proinflammatory IR-signature
As the release of proinflammatory cytokines is critical for the continuum of immune cascade culminating in the hepatocellular death, 
| HO-1 deficient neutrophils exhibit increased ROS and proinflammatory phenotype
We next focused on the neutrophil function in our model by analyzing the influence of HO-1 disruption in casein-elicited peritoneal neutrophil population. Indeed, Ly6G+ sorted neutrophils from mHO-1 KO mice were characterized by increased levels of ROS as 
| D ISCUSS I ON
This is the first study, to the best of our knowledge, which demonstrates the hepatoprotective function of recipient myeloid cellspecific HO-1. In the clinical arm, we found that posttransplant low HO-1 level was a reliable predictor of exacerbated hepatic IR-damage ( Figure 1D ). Posttransplant HO-1 reflected pretransplant HO-1 expression ( Figure 3A (Table S2/S3 ). In contrast, others have reported that cerebral cortex/hippocampus HO-1 levels in normal human brains showed a significant positive correlation with age, 30 whereas unstressed livers from aged mice had significantly more HO-1 compared with young counterparts. 31 Likewise, despite lacking statistical correlation, pretransplant HO-1 levels in our clinical study trended toward a positive correlation with donor age (r = 0.2771, P = .0514, Table   S2 ), whereas the relationship between donor age and HO-1 weakened in postreperfusion biopsies (r = 0.1422, P = .3245, Table S3 ).
Noteworthy, human liver grafts with perioperative HO-1 increase (at 2 hour postreperfusion) had significantly lower preoperative HO-1 levels ( Figure S7 ). Similarly, Geuken et al reported that human liver grafts with abundant pretransplant HO-1 showed decreased HO-1 expression after reperfusion (by 23%), whereas those with low pretransplant HO-1 levels were able to induce HO-1 at reperfusion. Human HO-1 gene expression is modulated by two functional polymorphisms in the gene promoter. First, a short (GT) n repeat polymorphism has been associated with enhanced transcriptional HO-1 activity. 32 Indeed, a short (GT) n repeat in the kidney graft was accompanied by a favorable posttransplant renal function and survival. 33, 34 Second, A(−413)T single nucleotide polymorphism (SNP) has also been identified as a functionally relevant variation of the HO-1 gene, whereas A-allele rather than T-allele of this SNP correlated with a higher promoter activity. 35 Interestingly, two studies 19, 20 Flow Cytometry Core Facility. We thank Ko Takanashi (UCLA-TPCL) for immunohistochemical assistance.
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